( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Me, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value ...
On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company ...